Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT06041438 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

Start date: September 29, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).

NCT ID: NCT06040372 Completed - Healthy Clinical Trials

A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects

Start date: March 16, 2020
Phase: Phase 1
Study type: Interventional

The aim of this 4-weeks randomized double-blind placebo-controlled single and multiple ascending dose study is to assess the Safety and Tolerability of LB54640 in Healthy overweight and obese subjects

NCT ID: NCT06037109 Completed - Healthy Clinical Trials

VIDAS® NEPHROCLEAR Reference Interval Study

Start date: July 18, 2023
Phase:
Study type: Observational

This is a multi-center sample analysis study in which urine samples previously collected from apparently healthy adult subjects, and subjects with stable chronic morbidities but without AKI in order to establish the reference range for the VIDAS® NEPHROCLEARâ„¢ CCL14 test.

NCT ID: NCT06035484 Completed - Healthy Clinical Trials

Effect of Seat Height and Angle on Wheelchair Foot Propulsion

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The purpose of the project is to explore the effect of differences in seat height and seat angle on bilateral foot propulsion using a manual wheelchair. The objectives of the study are to determine whether differences in seat height and seat angle impact: a) propulsion speed; b) knee range of motion used during propulsion; c) effectiveness of foot propulsion gait; and d) perceived difficulty with foot propulsion. A repeated measures designs allows comparison between 5 different seat height conditions and 4 different seat angle conditions to determine whether there are significant differences in outcome, and if so, which conditions provide better outcomes. Participants will propel a customized MWC through a standardized course using each seat configuration; the sequence will be randomized to reduce any learning effects.

NCT ID: NCT06032260 Completed - Healthy Clinical Trials

The Effects of a Fiber-enriched Bakery Product on Glucose, Insulin Values and Appetite

Start date: January 20, 2023
Phase: N/A
Study type: Interventional

The aim of the present pilot randomized controlled trial is to compare the effects of the following: 1)-panettone enriched with arabinoxylans (p-rich), 2)-panettone not enriched (p-standard) on blood glucose and insulin values, and appetite scores in 10 healthy volunteers.

NCT ID: NCT06030375 Completed - Healthy Clinical Trials

Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567

Start date: February 17, 2020
Phase: Phase 1
Study type: Interventional

The study was planned to consist of 24 healthy subjects in 3 dosing cohorts receiving a continuous i.v. infusion of KAND567 or placebo for 6 h (6 subjects on active and 2 subjects on placebo per cohort), with the option of two additional cohorts of the same size and group composition.

NCT ID: NCT06028464 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of BI 1810631 in the Blood

Start date: September 11, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A inducer carbamazepine on the pharmacokinetics of a single dose of BI 1810631 in plasma.

NCT ID: NCT06026761 Completed - Healthy Clinical Trials

Validation of Smart Garments for Metabolic Rate Estimation

Start date: March 28, 2023
Phase:
Study type: Observational

The goal of this observational study is to assess the use of Myant Skiin garments for the purpose of estimating metabolic rate in 20 adult (18-64 yrs) healthy participants. The main question it aims to answer is What is the accuracy of metabolic rate estimate from the Skiin algorithm utilizing Skiin data, as compared to observation and a gold-standard sensor? Participants will be asked to perform a number of scripted tasks and their data will be assessed and compared against gold standard wearable indirect calorimetry device (COSMED K5) measurements. .

NCT ID: NCT06025851 Completed - Healthy Clinical Trials

Intravenous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Start date: July 24, 2017
Phase: Phase 1
Study type: Interventional

The study is designed to investigate the safety and tolerability of CM-101 for the treatment of medical conditions involving inflammatory and fibrotic mechanisms such as non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc).

NCT ID: NCT06021574 Completed - Healthy Clinical Trials

A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody

Start date: June 28, 2019
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to study the tolerability, safety, pharmacokinetics and immunogenicity of investigational drug in healthy subjects. The main questions it aims to answer are: - Safety and tolerability of investigational drug. - pharmacokinetics and immunogenicity of investigational drug. Participants will receive a single intravenous administration of investigational drug or placebo. Blood samples are collected at specified time points.